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Abstract 
 
Research has shown that autologous progenitor-like cardiac spheroids, when delivered to an infarcted 
heart, are able to restore mechanical function. These spheroids are made by isolating and expanding 
autologous cardiac progenitor cells. Though these results are promising, the process for creating cardiac 
spheroids is inefficient and time consuming, requiring a large amount of cardiac tissue. For every 10,000 
cardiac myocytes in the heart there is only one cardiac progenitor cell; requiring a large amount of initial 
tissue. This clinical limitation could be overcome if cardiac myocytes, which are more abundant than 
cardiac progenitor cells, could be used to make cardiac spheroids. Research has shown that 
mesenchymal stem cells when co-cultured with adult cardiac myocytes cause the cardiac myocytes to 
behave like a progenitor cell. We found that, when co-cultured with mesenchymal stem cells, cardiac 
mycoytes could be made to form cardiac spheroid bodies. This was done by isolating adult myocytes 
from rat hearts and co-culturing them with human mesenchymal stem cells. After two weeks, cultures 
were observed to form spheroid bodies and the number of spheroids formed were compared to a pure 
myocyte control. Cardiac specific staining confirmed that the spheroids were made from the myocytes. 
It was also found that the mesenchymal stem cells, when co-cultured in the same well with the 
myocytes, form significantly more spheroids than myocytes treated with stem cell conditioned media. 
Further, no other cell type present in the co-cultures are able to create spheroid bodies when co-
cultured with mycoytes or stem cells. The ability to create cardiac spheroid like bodies from adult 
myocytes offers a way to overcome the limitations of the time needed and the large quantity of 
autologous cardiac tissue required to currently make these types of bodies.  
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Chapter 1: Introduction/Background 
 
The pumping of blood by the heart drives the transport of nutrients and gas throughout the 
body, a process necessary for maintaining normal organ function and homeostasis.  It is for this reason 
that the health of the heart is extremely important. Any compromise in the well-being of the heart is 
detrimental to overall quality of life. The heart is a muscle and the contraction of the muscle is what 
imparts pressure on the blood, driving it to the body. This is the mechanical function of the heart. 
Function can be compromised when part of the myocardium is damaged by oxygen deprivation caused 
by occlusion of the coronary arteries. The end result can be death of the downstream cardiac tissue, 
known as a myocardial infarction (MI). This dead tissue will not endogenously regenerate, resulting in a 
reduction of cardiac output and a therefore grave health concerns  1 2.    
1.1 Cardiac Disease 
 
Heart disease is a national as well as global threat to public 
health, it is estimated that by the year 2020 11.1 million people will 
die from its effects 3.  Each year, in the U.S. alone, 500,000 new cases 
of severe heart failure (HF) are reported, a condition in which an 
insufficient amount of blood is pumped throughout the body to 
maintain normal daily activity 2. Those who live with heart failure 
have a significantly reduced quality of life and are unable to perform 
Figure 1:  Blockage of the Coronary 
Artery (red arrow) and area of infarct 
(blue arrow). 
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a simple task such as climbing a flight of stairs without losing their breath.  
This reduction in cardiac function is caused by necrosis of the myocardium following an 
infarction4. When a coronary artery is blocked for a prolonged period of time the cells downstream die 
and that region of the heart loses contractile function4. The area of infarct is remodeled by the body and 
becomes a stiff scar 4. Figure 1 illustrates how a coronary occlusion, indicated with a red arrow, can lead 
to scarring of the downstream cardiac tissue, shown with a blue arrow. This stiff scar further impedes 
cardiac output as it is more rigid than the rest of the heart and 
therefore alters the regular mechanical pumping action during a 
heartbeat5. Figure 2, shows a cross section of an infarcted heart 
stained with Hematoxylin and Eosin (H&E). The infarcted area is 
outlined with a yellow dashed line, the discoloration of the infarct 
indicates the tissue no longer contains eosinophilic structures such 
as cell cytoplasm or protein. This suggests the tissue is no longer 
comprised of healthy cells and therefore is damaged, inhibited from 
behaving as normal cardiac tissue would. In order to restore normal 
cardiac function, the region of infarct must be replaced with active contractile tissue.  
Current treatments for heart disease primarily focus on returning blood flow to the infarcted 
region of the heart and do not address the need to replace the damaged tissue. The gold standard for 
care is to restore blood flow by either bypassing the occlusion with a vascular graft, referred to as a 
coronary artery bypass graft (CABG), or to mechanically open the blocked vessel with a balloon. 
Following reperfusion, using one of these techniques, a patient is given anticoagulants to prevent future 
plaque buildup and/or a stent is implanted to physically suppress occlusion6.  
Figure 2: H&E staining on a cross 
section of an infarcted heart. The 
discolored area outlined with yellow is 
the area of infarct. 
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 These treatments do not restore normal heart function as they fail to address the lost 
mechanical function due to the infarction resulting in a chronic reduction of ejection fraction (EF).  
Ejection fraction is the percentage of blood that is expelled from the heart during systole as compared 
to the total volume of blood in the heart at the end of diastole and is a way to quantify the ability of the 
heart to pump blood. A total allogeneic heart transplant or a left ventricular assist device (LVAD) is 
needed to restore the lost mechanical pumping force and reduced EF, both options are invasive and 
have high rates of mortality associated with them 7. Furthermore, the number of hearts available for 
transplantation, roughly 2000 a year, is grossly inadequate to satisfy the half a million patients currently 
suffering from heart failure 2.  LVADs, though more readily available than donor hearts, also have risks 
associated with them. They do not treat or heal the heart, instead they aid the movement of blood with 
an implanted mechanical pump.  As such, the use of LVADs is not an ideal method to treat HF and is 
generally used as a temporary measure to bridge a patient to transplant.  
Current treatments for myocardial infarction are inadequate as they fail to mechanically restore 
the heart to its pre-infarct state. Research has been focused on identifying a way to replace damaged 
myocardium.    
 
 1.2 Cellular Therapy  
 
In order to fully restore the lost contractile action of the heart after an infarct, the dead cardiac 
tissue must be replaced with new functional cells. These cells need to be able to actively contract in 
rhythm with the surrounding myocardium, as a native cardiac myocyte would.  To do this a cell must 
contain the proteins responsible for contraction as well as the proteins necessary for synchronized 
beating with the rest of the heart. Some proteins used by the myocyte to achieve contraction are: 
actinin, troponin, myosin heavy chain, and myosin light chain. The protein connexin-43 forms the gap 
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junctions between cells that allows for the electrical signal to travel through the heart, triggering a beat.  
A cell source that is able to mimic the native myocardium without posing serious health risk has yet to 
be developed 8 9 . The following cells have been explored as therapeutic options: skeletal muscle cells, 
embryonic stem cells, mesenchymal stem cells (MSC), induced pluripotent stem cells (IPSC), and cardiac 
progenitor cell-derived cardiospheres (CPCS). Table 1 below outlines some of the advantages and 
limitations associated with using each of these cells as a therapeutic agent for myocardial infarction.  
Table 1: The various cell types which have been researched for cardiac regeneration along with their advantages and 
disadvantages. Currently, no cell type contains the proteins necessary for synchronized beating without posing a serious 
health risk.  
Cell type  Advantage  Limitation  
Skeletal Muscle 10-15 Contain proteins necessary for 
contraction  
Do not electrically couple with 
native myocytes  
Can cause arhythmia  
Embryonic Stem Cells 16-20  Can be induced to differentiate 
into cardiac myocytes 
Risk of teretoma formation  
Induced Pluripotent Stem Cells 
16, 21, 22  
Can differentiate into mature 
cardiac myocytes 
Risk of teretoma formation.  
Can be carcinogenic 
Genetic manipulation 
Selecting pure population 
Mesenchymal Stem Cells 23-25 Shown to improve cardiac 
function when delivered to an 
infarct  
Do not contain proteins 
necessary for contraction 
 
Cardiac Progenitor Cell Derived 
Cardiospheres 26-29 
Can incorporate with native 
myocardium without eliciting 
host immune response.   
Low cell number  
 
The major limitation with current cellular based therapies is that they lack the ability to become mature 
electrically synched myocytes without the risk of becoming cancer or a teratoma 13, 30, 31. Another 
limitation is the ability to scale up the production of cells to obtain a clinically relevant cell number.  
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One attempt at using cells for cardiac regeneration involved transplanting autologous skeletal 
myoblast cells into damaged myocardium 10. These are the precursor cells to skeletal myocytes, the 
objective of their delivery to an infarct is to differentiate them into contractile cells. These cells would 
then be able to restore some of the lost cardiac function of the infarct. Skeletal myoblast are able to 
enter the cell cycle and undergo cellular division. The ability to form daughter cells is advantageous for 
replacing cells that are lost in a heart attack. Skeletal muscle cells, like cardiac myocytes are striated and 
contain the necessary proteins for contraction such as actinin, myosin heavy chain and troponin 32. 
However, unlike cardiac myocytes which are involuntarily controlled, these cells are voluntarily 
controlled and lack the electrical gap junctions or pacing ability to contract in rhythm with the native 
myocardium. This can even cause cardiac arrhythmias as the electrical signal that propagates through 
the heart, to begin a beat, can be disrupted or perturbed resulting in a non-synchronous contraction 32.  
For this reason, skeletal muscle cells do not hold promise as a treatment for MI.  
Embryonic stem cells (ESCs) are another cell type that was extensively researched for use in 
repairing damaged myocardium. ESCs are cells taken from a human blastocyst, which have the potential 
to differentiate into any cell type. They are relevant for cardiac regeneration as they have been 
differentiated into cardiac myocytes and delivered to a mouse infarct model 33. Though this method was 
effective in restoring lost contractile function post MI, the use of ESCs is associated with the formation 
of teratomas, tumors containing cell types of all three germ lines 34; 35. These growths within the body 
can be detrimental to health, therefore rendering ESCs unfit for human use. There are also ethical 
concerns associated with destroying an embryo to harvest the ESCs. Another limitation is that the ESCs 
may instil a rejection response from the host as they the cells of another individual. This would mean a 
patient would be required to take immune suppressing drugs for the rest of his/her life.  
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 A newer technology that has been applied to the field of cardiac regeneration is the genetic 
reprogramming of fibroblasts into stem cells, otherwise known as induced pluripotent stem cells (IPSCs) 
36. These IPSCs can be differentiated into cardiac myocytes and subsequently delivered to an infarct37. 
Literature has shown that these cells do improve cardiac function post MI, but like ESCs, there are health 
risks associated with their use. The genetic manipulation of these cells makes them prone to developing 
into cancerous tumors, which can severely harm or kill the patient 38. As such, a large effort must be 
made to purify the population of differentiated myocytes from the IPSCs. A second limitation is the low 
efficiency of reprogramming to a stem cell state. These are the two major limitations of using IPSCs for 
cardiac repair.  
 A cellular based approach to treating MI offers a means by which the area of damaged 
myocardium can be restored to functional tissue. The challenge is to find a viable cell source that can 
improve contractile force without posing a serious health risk to the patient. The first three cell types 
mentioned in Table 1, skeletal myoblast, ESCs, and IPSCs currently do not fulfill these criteria. They are 
able to differentiate into contractile cells, but each have inherent health risk associated with them. The 
skeletal myoblast do not contain the necessary proteins to electrically couple with the myocardium and 
as such can cause cardiac arrhythmias. A potentially dangerous condition for the patient. The health risk 
the ESCs and IPSCs pose is that they may develop into tumors when delivered to the heart. This can 
occur if one of the delivered cells is undifferentiated and begins to proliferate and differentiate into an 
unwanted tissue type. This is also dangerous for the patient. The last two cell types in table 1, MSCs and 
cardiac progenitor cell derived spheroids have shown the most promise in current research 39; 5. These 
cell types have been shown to safely reduce infarct size in human clinical trials.  
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1.3 MSC reduce infarct size Post MI 
 
Bone marrow derived MSC have some ability to mitigate the effects of cell death in the heart 
following an infarction 23. When injected in the border region of a mouse infarct model 68% percent of 
the necrosed area formed new myocardium after 9 days 23. Further, myocytes within this region were 
found to be undergoing cellular proliferation, indicated by positive BRDU staining. A new vascular 
network also formed within the regenerated myocardium 40. These results translated into human clinical 
trials with patients suffering from ischemic cardiomyopathy. Autologous mesenchymal stem cells were 
delivered via transendocardial intramyocardial injection to the infarcted region. One year after the 
procedure, infarct size had significantly decreased 41. These findings illustrate that mesenchymal stem 
cells can promote the recovery of the scar formed post MI back to live tissue. Unlike ESCs and IPSCs, 
MSCs do not pose any serious health risk to the patient, when delivered to the heart 41. In this trial, the 
MSCs proved to be immune privileged, eliciting no response from the host immune cells 41. Despite 
these positive results, MSCs fail to significantly increase the reduced left ventricular ejection fraction 
(LVEF) caused by a MI, a critical parameter of cardiac health 9.   
  
1.4 CPSs are able to improve ejection fraction post MI  
 
Currently, a promising technology for cellular MI therapy is the use of cardiac progenitor cell 
derived spheroids (CPSs). These cells were directly compared to MSCs in their ability to restore 
mechanical function when delivered to a mouse model and it was found that the CPSs were able to 
better restore left ventricular ejection fraction (LVEF) than the MSCs 42.  
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 Progenitor cells are undifferentiated stem like cells that are able to differentiate to one specific 
tissue type. CPSs, a type of progenitor cell, are made by isolating a population of autologous cardiac 
progenitor cells from a cardiac biopsy and then growing the cells in culture, after which, they form 
multicellular spheroid bodies12 43, 44. Unlike mature cardiac myocytes, some of these cells express Ki67, a 
mitotic indicator located in the nucleus, and are not striated nor rectangular. When implanted into a rat 
heart these cells demonstrated the ability to contract and expressed cardiac specific proteins 42. This 
translated into an ability to improve cardiac ejection fraction in a rat infarct model as compared to an 
infarcted heart injected with just medium 28. When these cells are delivered to a human heart following 
a MI, ejection fraction is also significantly improved and negative cardiac remodeling is reduced 11. This 
was demonstrated in a human clinical trial called Cardiac Stem Cells in Patients with Ischemic 
Cardiomyopathy, SCIPIO. A right atrial biopsy was taken from 20 post infarct patients who were electing 
to receive a CABG. The cardiac progenitor cells were isolated from the biopsy and expanded. These cells 
were then delivered with the vascular bypass graft and left ventricular ejection fraction (LVEF) was used 
as a way to measure cardiac function. LVEF is the percentage of blood that is ejected from the left 
ventricle using the quantity of blood at the end of diastole as the basis for comparison. After 1 year, 
LVEF, on average, improved 8% and following 4 years, LVEF improved 12%. Though these gains are 
modest, they demonstrate the ability of CPSs to return mechanical function to a damaged human heart.  
Despite these promising results, there is a major limitation associated with the creation of the 
cardiac spheres. The population of C-kit positive cells, a marker for cardiac progenitor cells, within 
normal cardiac tissue is very small, for roughly every 10,000 myocytes it is estimated there is one cardiac 
progenitor cell 45. C-kit is a surface protein that acts a receptor for stem cell factors that can trigger 
proliferation or differentiation 46. This is significant as adult cardiac myocte cells do not possess c-kit, 
and it’s presence on a cell suggest the ability of that cell to proliferate or differentiate. The presence of 
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C-kit on a cardiac cell is one parameter used to define it as a cardiac progenitor cell. As these cells are 
rare in the heart, a large amount of biopsied tissue is required in order to derive a clinically significant 
number of CPS.  The process of isolating the progenitor cells from a cardiac biopsy wastes a substantial 
number of differentiated cardiac myocytes. If there was a way to use the entire biopsy, the amount of 
tissue taken from a heart could be drastically reduced.  Additionally, CPSs are cultured for 65 days 
before being harvested for use, a relatively long period of time for a MI patient waiting for treatment 9.  
One advantage that CPSs may have over other cells intended for cardiac regeneration is they are 
3D structures unlike other cells which are cultured on a 2D surface. The 3D morphology of the CPSs is 
more like the environment that cells in the heart experience than a 2D culture. One reason for this is the 
entire cell is in contact with other cells around it, this may change the signaling that the cell experiences. 
Another difference between 2D and 3D culture is the cells within the spheroids are anchored to material 
that is closer in stiffness to normal cardiac tissue. Tissue culture plastic is stiffer than heart tissue, this 
can play a role in cellular behavior.  CPSs hold promise as agents for cardiac regeneration, but a more 
efficient way of deriving a cell type similar to these spheroid bodies is needed.  
 1.5 Myocyte Proliferation and Reprogramming 
 
Until recently, it was thought that cardiac myocytes were terminally differentiated and unable 
to undergo mitosis. Recent literature has suggested that this is not the case. It was found that a baseline 
rate of 1% of myocytes in the heart regenerate 47. Additionally, it was discovered that following an 
infarction, some of the surrounding myocytes reenter the cell cycle 40. These two findings suggest that 
cardiac myocytes are not terminally differentiated, but instead, are able to proliferate and form 
daughter cells. This is relevant for treating heart failure as a proliferating myocyte is similar to a cardiac 
progenitor cell, a cardiac cell that is not fully differentiated. As such, a proliferating myocyte may form 
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spheroid bodies similar to CPSs, which have been shown to improve LVEF post-infarct. Being able to use 
myocytes to form these spheroid bodies would be advantageous as they are far more abundant in the 
heart than cardiac progenitor cells, requiring a smaller biopsy to harvest the same number of cells.    
For a myocyte to undergo cellular division it must alter the arrangement of its organelles as well 
as its general shape. The sarcomere within in the cell disassembles and the cell loses its striated 
appearance. Furthermore, the cell changes from being long and rectangular to globular and round. 
Within the nucleus, the protein Ki-67 acts to aid in DNA replication. These changes in appearance and 
protein expression can be used as clues to determine if myocytes are proliferating and exhibiting 
behaviors similar to that of a stem cell. 
One important question is why are CPSs well suited for regenerating damaged myocardium? The 
hybrid nature of CPSs, containing both proteins associated with stem cells and differentiated myocytes 
may offer some clues. The stem like proteins they express, such as ki-67, a protein used in DNA synthesis 
and associated with cellular mitosis, suggest they are able to proliferate. Proliferation is advantageous in 
the context of myocardial regeneration as more of the dead or damaged cells can be replaced. Proteins 
found in mature myocytes, like actinin, are needed for the sarcomere of the cell to assemble. It is the 
sarcomere that is responsible for mechanical contraction of the cell and therefore is required for beating 
to occur. The presence of proteins associated with stem cells as well as mature myocytes is one reason 
CPSs may be effective as therapeutic agents for myocardial repair.   
 
  
 
1.6 Stem cells have the potential to reprogram cardiac myocytes  
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Research done by Rodriguez et al. showed that in co-culture, mouse cardiac myocytes and 
adipose derived stem cells (ADSCs) fused with one another 48. This is not a novel phenomenon as most 
types of stem cells can fuse with somatic cells, such as neurons. Myocytes that fused with the ADSCs 
expressed C-kit and Ki67, suggesting these cells were moving to a more progenitor-like state and 
proliferating, similar to that of cardiac progenitor cells 48, 49. Also similar to cardiac progenitor cells, the 
fused myocytes began to form multicellular spheroid bodies. These spheroid bodies, like CPSs, also 
expressed GATA-4, NKX-2.5, and MEF2C. Human DNA could not be found in the spheroid bodies, 
showing they were exclusively derived from the murine cardiac myocytes, similar to the way that CPSs 
are exclusively derived from autologous cardiac cells. The stark resemblance in gene expression and 
phenotype of these stem cell induced cariospheres to CPSs suggests that they would have similar 
positive implications if used for MI therapy. Rodriguez et al even reported witnessing their spheroid 
bodies differentiate into myocytes when delivered to the heart, though have yet to publish further 
information or data about this 48.  
Rodriguez et al. also co-cultured MSCs with the isolated mouse myocytes. Like co-culture with 
ADSCs, the myocytes expressed GATA-4, MEF2C, NKX2.5 and Ki-67. It was not reported if the MSC-
myocyte co-culture yielded spheroid bodies.  
The major limitation with the study done by Rodriguez et al was a low rate of myocyte 
reprogramming. The group reported only 0.1% of myocytes appeared to take on the appearance and 
phenotype of a cardiac progenitor cell when in co-culture with ADSCs 48. This could be a result of poor 
myocyte health after isolation or a limitation of the ADSCs. The potential of this study is a way to create 
a cell type similar to that of CPCS using mature myocytes, which are significantly more abundant in the 
heart than progenitor cells. A more effective way to derive these stem cell induced spheroids is required 
as only 0.1% of myocytes were reported to take on the phenotype of a CPSs.   
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1.7 Potential of MSCs for more efficient creation of spheroids.  
 
Human mesenchymal stem cells (MSCs), when delivered to an infarcted heart, have been shown 
to reduce infarct size 24. Despite these positive findings, MSC treatment is not an ideal therapy. 
Restoration of cardiac contraction to the pre-infarct state is not achieved as the mesenchymal stem cells 
do not appear to differentiate into cardiac myocytes. This suggests that the MSCs are mitigating the 
damaging effects of an MI without actually directly replacing the lost tissue. This effect could be 
attributed to either paracrine factors, cell to cell contact without membrane fusing or fusing of the 
cellular membranes 48. 
Although it has been shown that the presence of mesenchymal stem cells in proximity to an 
infarct can lessen the negative impact of a MI, the exact reason for this is unknown. Several possibilities 
are: MSC cardiac differentiation, proliferation of the native myocardium, or the release of cardiac 
preserving paracrine factors. Cardiac differentiation is unlikely as literature shows that MSC in direct 
contact co-culture with cardiac myocytes do not take on a cardiac lineage 50.  It is possible that the 
reduction in scar size, observed with MSC therapy, can be attributed to myocyte proliferation induced 
by the MSCs. MSCs have been shown to secrete Insulin like growth factor, (IGF) 51. IGF is an important 
growth factor in inducing proliferation of myocytes in human development and cardiac myocyte 
proliferation in adult Zebra Fish 52, 53. This gives reason to suspect that IGF may have the potential to 
induce cardiac myocyte proliferation of mature cells. MSCs may also benefit the native myocytes by 
releasing anti-apoptotic factors, aiding them in surviving the harsh post-infarct environment.  
 The result of prolonged co-culture of MSCs and cardiac myocytes has not been studied. It 
remains to be known if MSC myocyte co-culture will give rise to cardiac spheroid bodies. Further, if 
cardiac spheroids do form, this method of deriving spheroid bodies may be more efficient than culture 
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with adipose derived cells? Evidence suggests that MSCs have more potential to induce myocyte 
reprogramming than adipose derived stem cells as they secrete significantly larger amounts of Insulin 
like growth factor (IGF) 51 .IGF has been shown to direct the proliferation of ventricular myocytes in 
development, and is a required factor in cardiac repair of zebrafish hearts 52; 53}. This fact could allow 
MSCs to overcome the obstacle of low efficiency of cardiac spheroid development observed with ADSC 
co-culture, reducing the amount of culture time needed to derive a clinically relevant number of cardiac 
spheroids.  
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Chapter 2: Hypothesis and Aims  
 
Based on the prior research described in the last section, we hypothesized that after prolonged 
direct contact with MSCs, myocytes will form cardiac derived spheroids, a potential cell source for 
regenerating infarcted tissue. In order to test this hypothesis, cardiac myocytes were isolated from 
whole rat hearts and cultured with mesenchymal stem cells. Following two weeks of co-culture, 
spheroids were counted and compared to that of a pure culture of myocytes, MSCs, and cardiac 
fibroblasts.  Spheroids will be stained for actinin to verify a cardiac lineage, and Ki-67 to determine if 
proliferation was taking place within the spheroids. Further, the necessity of direct cell-to-cell contact 
between the MSCs and myocytes will be assesed by attempting to form spheroids without 
MSC/myocyte contact.  
Specific Aim 1: Determine if cardiac myocytes co-cultured with MSCs form cardiac spheroids  
For the first aim, we hypothesize that co-culture of myocytes and MSCs will yield cardiac 
spheroids containing proliferating myocytes. To test this, cardiac myocytes were isolated from adult rat 
hearts and cultured with MSC. After two weeks cultures were examined for cardiac spheroid formation 
and the total number of spheroids was counted.  Further, cells within the spheroids were stained for the 
proliferative marker Ki-67. Some samples cultured for one month in an effort to track the growth of the 
spheroids following formation.   
Specific Aim 2: Evaluate the role of non-myocyte cardiac cells in cardiac spheroid formation  
 For this aim we hypothesize that both myocytes and stem cells must be present in 
culture for cardiac spheroids to form. We postulate that both myocytes and MSCs are necessary 
elements in cardiac spheroid formation, co-culture with other cell types will not yield cardiac 
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spheroids. To test this, myocytes and stem cells were cultured alone and after two weeks of 
culture examined for cardiac spheroid formation. The number of spheroids were counted and 
compared the number of spheroids formed in a co-culture of MSC and myocytes. Further, MSCs 
and myocytes were each co-cultured with the non-myocyte cells extracted during the cardiac 
myocyte isolation process. These cultures were also examined for cardiac spheroid formation 
and compared to a MSC/myocyte co-culture.  
 From the results of these experiments it can be determined if MSCs or myocytes can 
form cardiac spheroids when either cultured alone or with non-myocyte cardiac cells.  
Specific Aim 3: Determine the role of MSC in cardiac spheroid formation  
For the last aim, we hypothesize that for spheroid formation, direct co-culture between the 
myocytes and MSCs is advantageous. Furthermore, we hypothesize that the ratio of myocytes to MSC is 
proportional to the number of spheroids that will form in culture. To test if stem cell secreted paracrine 
factors were responsible for spheroid formation myocytes were exposed to conditioned medium which 
has been used in culture with MSCs for 24 hours. Myocyte media was changed every 2 days and 
following two weeks of culture, spheroid number was counted and compared to a control group of 
myocytes and MSC grown in direct contact.  
 To test the effect that myocyte stem cell ratio has on colony formation, varying proportions of 
myocytes to MSCs were used in direct contact culture. Following two weeks of culture, spheroid number 
was counted and statistically compared between groups.  
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Chapter 3, Aim 1: Determine if co-culture of MSC with myocytes form 
cardiac spheroids 
 
The first aim was to establish if direct contact co-culture of MSCs and cardiac myocytes would 
result in the formation of cardiac spheroids. This is a novel method for making spheroids which hold 
promise as therapeutic agents post MI. The procedure for isolating the myocytes and co-culturing them 
with the MSCs is described below.  
3.1 Method: cardiac myocyte isolation 
 
The treatment of the rats used in this study was reviewed and approved by the WPI Institutional 
Animal Care and Use Committee.  The rats were retired breeders and predominantly female. As they 
were retired breeders the rats were all adults, 27 rats were used throughout the course of this study. 
The Sprague Dawley rats were euthanized and hearts were harvested within 5 minutes and placed in a 
50 ml conical tube filled with 20mililiters of KB solution (Appendix A). Each conical tube was then 
sprayed with ethanol and introduced into a class II bio-safety cabinet, and the content of the tube was 
emptied into a petri-dish. Forceps were used to gently squeeze the heart in order to remove any 
remaining blood. The atria were removed with surgical scissors and discarded.  The ventricles were 
moved to a new petri-dish with 20ml fresh KB and subsequently cut into roughly 1cm wide strips.  
Attention was given as to cut the strips along the length of the fibers of the heart. These strips were 
incubated in a 50ml conical tube with 20ml fresh KB and 200ul Liberase DH (Sigma, 11988468001; 
Appendix A) for ten minutes at 37◦C. The contents of the tube were then poured into a new petri-dish 
and pulled apart with two forceps until the tissue pieces were small enough to fit through a 25ml 
pipette tip. Using a 25 ml pipette, KB, liberase DH, and tissue solution was triturated for 7min. The tissue 
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was then allowed to settle on the bottom of the tube and the top 14mls were removed and centrifuged 
at 500rpms for 5 minutes. The supernatant was aspirated and the cell pellet was suspended in 5mls KB; 
this solution was then agitated and centrifuged again in the same manner. The cell pellet was then re-
suspended in 1ml KB and a hemocytometer (Marienfield Neubauer-improved, Ref 06 500 30; 
0.0025mm2) was used to determine the total cell count using the formula below, Equation 1. Each round 
of triturating yielded roughly 50,000 to 1 million cells. This large range of cellular yield can be attributed 
to the batch to batch variation of the liberase as well as variation in liberase incubation time. Further, 
the amount of mechanical force applied to the cells from trituration can alter the yield as well.  
Equation 1: Cell counting with a hemocytometer 
 
Using total cell number, additional media was then added to attain the desired cellular density of 
20,000cells/ml. 200ul of the diluted cell suspension was plated into a 4well chamber slide for a total cell 
number of 5,000 myocytes per well. CC2 coated four well chamber slides were used as vessels for 
culture (Nunc Lab-Tek s6690). The coating on these slides is proprietary, but stated to mimic polylysine 
and “provide binding sites optimal for fastidious cells” on the Nunc Lab-Tek webpage. Each well was 
1.7cm2 in area, equating to a myocyte density of roughly 2,900 myocytes/cm2. Wells were washed with 
two washes of Phosphate Buffered Saline (PBS) after 30mins of incubation. The washed myocytes were 
then incubated with 500ul of serum free Dulbecco’s Modified Eagle’s Medium (DMEM Bio-Whittaker 12-
604F) with 1%Penecillin/streptomycin added for one day before co-culture was begun. 
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3.2 Method: Myocyte co-culture with MSC 
 
A solution of hMSCs was then prepared for plating with the myocytes as follows. A T-75 flask 
(Becton Dickinson Labware, #35-3136) were seeded with 500,000 hMSCS (Lonza, #PT-2501) and allowed 
to reach 70-90% confluence. Cells were then washed using Phosphate Buffered Saline without Calcium 
and Magnesium and 5ml of Trypsin (Clonetics CC-5002) was added to the T-75 flask. The flask was then 
incubated for 5mins at 37C° and 5% CO2. 5mls of 10% FBS in DMEM was then added to the flask to 
deactivate the trypsin and the contents of the flask was removed and centrifuged for 5mins at 1000rpms 
in a 15ml conical tube. The cell pellet was then suspended in 2mls of media and 10uls were removed, 
added to 10 microliters of Trypan Blue solution and subsequently loaded into a hemocytometer. 
Equation 1 was used to calculate total cell number. Based on total cell number a quantity of cell 
suspension was added to the wells of the 4 well chamber slides such that 5,000 hMSCs were seeded per 
well. Following co-culture, cells were grown in an incubator at 37C° and 5% CO2 for time points of two 
weeks and one month. 10% FBS in DMEM was used to culture the cells and media was changed every 
two days. A 4 well chamber seeded with 5,000 myocytes/well was cultured without adding MSCs as a 
control. In each well 5,000 mycoytes were plated and media was changed, one day after plating and 
every other day after that. The medium used was DMEM with 10% FBS 1% P/S. This experimental group 
establish if a pure culture of myocytes would give rise to spheroids. MSCs were also culture alone at 
5,000 cells per well with 10%FBS 1%P/S. Media was changed every other day to mimic the treatment of 
the MSCs in co-cultures. This experimental group was used to establish if MSCs alone could generate 
spheroid bodies.  
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3.3 Method: Colony Counting  
 
After two weeks of culture, wells were examined for spheroid formation. A spheroid was 
defined as 5 or more cells in intimate contact. An inverted microscope was used to examine the wells. 
The number of spheroids in each well was counted first by one person, and then by 2 additional 
independent observers to confirm there was no bias in the counts. 
 
Figure 3 : Wide field image of a co-culture taken with an inverted microscope (A). The pattern used to count all of the 
colonies within the well (B). 
Figure 3 above portrays the technique used to ensure the entirety of the well was counted. An inverted 
microscope was used to inspect the culture surface for spheroids (A) based on the above definition. The 
scanning technique shown in (B) was implemented. This systematic approach begins by scanning the top 
row and then using a reference at the bottom of the field of view to shift down one field. The observer 
then scans horizontally and again shifts down the width of the field of view. By using this approach, all 
colonies can be counted effectively and accurately.  
A B 
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 As spheroids were defined as 5 or more cells in contact, a method for counting them was 
developed. This was done to standardize what can and cannot be counted as a spheroid allowing for 
comparison between wells and experiments. 5 cells was chosen as an arbitrary number and nuclei were 
not used a way to count cells as some myocytes are bi-nucleated while others are mononucleated. Size 
of the spheroids was not used as the shape of the spheroids is not uniform or consistent. Clusters of 
cells were identified in the wells and then the outline of the individual cells within the cluster were used 
to count total cells in contact. 5 or more cells in contact defines a spheroid. This process is illustrated in 
Figure 4. After two weeks of co-culture, the number of spheroids counted in the control group of pure 
myocytes was compared to the number of spheroids counted in the myocyte/MSC co-culture group. A 
Student’s T-test was used with a null hypothesis that the number of spheroids between the two groups 
was the same. A p-value of 0.05 was used. 
 
Figure 4: Method for counting cells in contact. Clusters of cells are identified (A.) then the outline of cells are used to count 
the total number in contact (B). 5 or more cells in contact define a spheroid. 
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3.4 Method: Immunohistochemistry  
 
Immunohistochemistry (IHC), targeted protein fluorescent tagging, was used to detect the 
presence of two proteins, Ki-67 and alpha-actinin. The presence of the cytoskeletal protein alpha actinin 
indicates cells have a cardiac lineage, while Ki-67 is a protein, found in the nucleus, associated with the 
replication of DNA and is expressed in cardiac progenitor cells. 
All immunocytochemistry was done using the same protocol. Slides were immersed in -5◦C 
acetone for 10 minutes to fix the sample. Three washes in PBS for 5 minutes each followed in order to 
remove the acetone. Samples were then blocked in the serum of the species in which the secondary 
antibody was made (ki-67 goat, actinin rabbit) for 30 min at a concentration of 5%. After blocking 
primary antibody (Mouse monoclonal anti-actinin 1:100, Sigma-Aldrich, # A7811; Rabbit monoclonal ki-
67 1:50, sc-23900 Santa Cruz Biotechnology) was placed on the positive controls and the samples were 
left untouched 12-15 hours at 4C. Negative controls were incubated alongside the positive controls in 
the serum that the blocking step was done with. PBS washing was done three times for 5 minutes to 
remove all non-absorbed primary antibody. Both the positive and negative controls were then incubated 
in the secondary antibody for 1hr at room temperature (RT) at a concentration of 1:400 (AF488 for 
actinin, Invitrogen Alexa Fluor 488 Rabbit anti-Mouse, # A11059; AF568 KI-67, Invitrogen Alexa Fluor 568 
Goat anti-rabbit A11079). The purpose of the negative control is to determine if there is non-specific 
binding of the secondary antibody to the cells. A fluorescent signal in the negative controls would 
indicate this. Three washes with PBS for 5 minutes were done. Samples were then counterstained with 
Hoechst (1:6000) for 5 min and washed for a final three times for 5 min each with PBS. Cytoseal 60 was 
used to coverslip.  
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3.4.1 Click-it EdU Cell Proliferation Assays  
 
In order to detect newly synthesized DNA in the myocyte/MSC co-cultures a Click-it EdU 
proliferation assay was run (Life technologies, C10340).  EdU (5-ethynyl-2’-deoxyuridine) was thawed 
and a stock solution was prepared in accordance with the instructions on the company webpage (Click-it 
EdU Manuals and Protocols). A co-culture of 5,000 myocytes and 5,000 MSCs in a 4 well chamber slide 
was used for this experiment. Using the stock solution of EdU a 10 micromolar solution of EdU was 
made with DMEM and 10% FBS 1% P/S. This culture media was prepared immediately before being 
incubated with the co-culture. New 10 micromolar EdU media was placed on the co-cultures daily from 
day 0 of until day 5 of co-culture. After day 5 of co-culture the cells were fixed in 4% paraformaldehyde 
for 10 minutes and then washed three times with PBS for 5 minutes each. The cells were then incubated 
with 0.5% Triton-X-100 in PBS for 20 minutes. Following Triton-X-100 treatment, cells were washed 3 
times in PBS for 5 minutes each. A working solution of Alexa Fluor azide 647 was made in accordance 
with the instructions on the Life Technologies website (Click-it EdU Manuals and Protocols). 100ul of this 
working solution was added to the cells and incubated in a dark environment for one hour. Following 
this step, three washes with PBS for 5 minutes each were done. A nuclear counterstain with Hoechst 
was then done by incubating a Hoechst solution in PBS (1:6000) and incubating it for 5 mins on the cells. 
Three washes with PBS were then done. The cells on the 4 well chamber slide were then mounted with 
cytoseal 60 (Richard Allan Scientific, 8310-4) and cover-slipped. 
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3.5 Method: Imaging  
 
Live cell imaging was done with an inverted microscope (Leica DMIL). Cells were imaged through 
either the bottom of a 24 or 96 well plate or a 4 well chamber slide. Different magnification objectives 
were used to image the cultures, the objectives included, 4x, 10x, 20x, 40x. Images were taken using 
visible light. The Leica Application Suite software was used for capturing and processing the images.  
To image the fluorescently stained cultures, a Leica Upright Fluorescence Microscope DMLB2 
was used. Alexa fluor 488 fluorescent tags were imaged with a Chroma L5 FITC filter cube, Alexa fluor 
566 secondary was imaged with a Chroma N3 Texas Red filter cube, Alexa fluor 647 secondary was 
imaged with a QDOT 655 cube, and Hoechst nuclear staining was imaged with a Chroma A4 DAPI filter 
cube. Oil immersion objectives were also implemented to take 40x images. The Leica Application Suite 
software was used for capturing and processing the images. 
A Leica confocal microscope was used to make 3 dimensional movies of the co-cultures by 
incrementally imaging sections along the vertical axis and compiling them together. Images were taken 
at 40x. This scope was synced with Leica software to capture and process the images. 
 3.6 Method: Tracking area of cardiac spheroids 
 
To track the change in area of cardiac spheroids from 2 weeks to one month, live cell imaging, as 
described above, was implemented. Cardiac myocytes and MSCs were co-cultured in a 24 well plate. 
This differs from the 4 well chamber slide that was previously used. Myocytes were still seeded at 
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quantity of 5,000 cells/well though the area of the well was 1.91cm2 equating to a new cell density of 
roughly 2,600 myocytes/cm2 as compared to 2,900 myocytes/cm2 with the 4 well chamber slides. At two 
weeks, wells were examined for spheroid formation and any cardiac spheroids found were imaged in 
order to measure their surface area. Image J software was used for the analysis, the outline of the 
spheroids were traced using the software. The total area was found by setting the scale in image J using 
a scale bar to define the pixel to distance ratio. With this information image J is able to calculate the 
total area of an outlined region. All of the spheroids for the time point were then averaged. This same 
procedure was done at one month and the averages for the two groups at each time point were 
compared using a Students T test with a p-value of less than or equal to 0.05. The null hypothesis was 
that spheroid size was the same at 2 and 4 weeks.    
 3.7 Method: Low cell count co-culture 
 
In order to detect if myocyte number increases as a result of co-culture, roughly 1 to 5 myocytes 
were co-cultured with MSCs. This was done in order to count the myocytes over time. 10 microliters of 
standard post isolation myocyte suspension was diluted with 5mls of KB solution. After the solution was 
agitated to ensure a homogeneous mixture, 10 microliters of the diluted suspension was placed in the 
well of a 96 well plate. One hour following plating wells were washed with PBS. The myocytes were then 
incubated at 37oC for one day. After one day of culture MSCs were added to the wells, 10 MSCs were 
added to each well. This number was chosen to ensure an MSC was in proximity with the myocyte, but 
not to alter the ratio of myocytes to MSCs substantially. Prior to adding the MSCs to the wells, the 
number of myocytes in each well was counted using an inverted microscope. The co-cultures were 
grown for 10 days, allowing enough time for the MSCs to manipulate the myocytes, and the total 
number of myocytes was counted again. Co-cultures were grown with DMEM with 10% FBS and 1% 
penicillin/streptomyosin. A culture of pure myocytes, plated in the same fashion, was run alongside the 
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co-cultures as a control. This control was used to examine if myocytes in pure culture would increase in 
number. The change in myocyte number was then compared using a Student’s T-test with a null 
hypothesis of the two groups being the same. A p-value of 0.05 was used.   
 
3.8 Results: Co-culture yields cardiac spheroid formation  
 
After two weeks of direct contact 
myocyte/MSC co-culture, round multicellular 
spheroid bodies spontaneously formed within the 
wells. For consistency, spheroid bodies were 
defined as 5 or more cells in intimate contact 
resting on the feeder layer of MSC. Using this 
definition, the total number of cardiac spheroid 
bodies formed in the myocytes/MSC wells was 
compared to wells containing solely myocytes. Figure 
5 shows that in the control group of just myocytes an 
average of 1.5 colonies formed while in the co-culture 
group an average of 64.5 colonies formed per well.  This suggest that spheroid formation is not 
something that myocytes spontaneously do when cultured alone. 
Figure 5: Average number of colonies counted per well 
following 16 days of culture. Co-culture yields a 
significantly greater number of spheroids as compared to 
lone myocytes using a Students T-test with a p-value of 
0.05. 
Pure myocytes 
*
 
    
*= P ≤ 0.05 
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  Qualitatively the pure cultures of myocytes appeared different than the cells in co-culture (p-
value of 0.05. The null hypothesis was that the number of spheroids in each well after 14 days was the 
same). Figure 7 (A) shows the co-culture of myocytes and MSCs. Large spheroid bodies have 
spontaneously formed in the culture. These spheroids are starkly different in appearance to the 
surrounding cells. They are darker, larger, and round while the surrounding cells are lighter in color and 
smaller. The yellow arrows indicate where the spheroid bodies have formed. Very few of the myocytes 
in culture remained by themselves. The pure culture of myocytes shown in Figure 7 (B) is void of any 
spheroids, it can be seen in the 
image that the cells are 
predominantly separate. Figure 6 (A) 
shows a 40x image of a spheroid 
body derived from Myocyte/MSC 
Figure 7: Spheroids have formed in the myocyte/MSC co-culture (A), indicated by yellow arrows. The pure culture of 
myocytes is void of spheroids (B). 
Figure 6: 40x magnification of myocyte/MSC derived spheroid body. The 
spheroid is round and granular in appearance (A). : Hoechst staining, which 
stains cellular nuclei blue, shows spheroids are multicellular (B). 
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co-culture. The spheroid is round with a granular appearance.  
Within the spheroid there appear to be smaller round forms that make up the entirety of the 
sphere. Hoechst staining revealed that these bodies were in fact comprised of many cells, as seen in 
suggesting these smaller round forms are individual cells figure 6 (B).  
3.9 Results: spheroids stain positive for alpha-actinin 
After finding that myocyte/MSC co-culture resulted in the formation of spheroids, actinin 
staining was done to determine the origin of the cells within the spheroids. Alpha-actinin is a protein 
specific to cardiac myocytes and, therefore, the presence of this protein indicates a cardiac lineage1. 
Figure 8 below shows a cardiac colony that has been stained for alpha-actinin (green). A substantial 
proportion of the cells in the spheroids appear to stain positive for actinin, while cells outside of the 
spheroid did not stain positive for alpha-actinin. Therefore, it can be concluded that the spheroid bodies 
are primarily derived from the isolated cardiac myocytes and it is appropriate to call this assembly of 
cells a cardiac spheroid body. The mesenchymal stem cells are likely not responsible for the positive 
signal as they do not differentiate into cardiac 
myocytes when in myocyte/MSC co-culture, and 
therefore do not produce actinin 48. Additionally, cells 
within the colonies exhibited an appearance 
resembling myocytes and not stem cells. Cells were 
darker in appearance compared to a MSC and some 
even retained striation like a mature myocyte. Based 
on positive actinin staining and phenotype it can be 
Figure 8: Spheroid bodies stain positive for actinin. Green 
signal indicates positive actinin staining while blue 
staining shows the location of the nucleus. Green signal is 
predominantly found in the spheroid bodies suggesting 
spheroids are predominantly comprised of myocytes 
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determined that the spheroid bodies are largely made up of myocytes.  
3.10 Results: Myocytes in co-culture lose striation 
 
 Within 2-3 days following the beginning of co-culture, cardiac myocytes lose their striated 
appearance, as well as their rectangular shape. Figure 9 is a series of images taken over time from when 
the myocytes are isolated until fourteen days after co-culture, though are not of the same cell. These 
images capture this transition from a rectangular striated cell into a round amorphous shape.  
 
Figure 9: Representative images of myocyte appearance over time during cell culture (not the same cell). From day 0 to day 
14. At day 0 myocytes are elongated, rectangular and striated (A). Day 1 stem cells are added to the culture (B). Day 2, stem 
cells attach and localize with the myocytes (C). Day 5, myocytes begin to lose striation, rectangular shape, and ball up (D). 
Day 14, large multicellular spheroid bodies have formed (E).  
These types of changes in cellular behavior can offer some insight when trying to determine what 
changes are occurring within a cell. At Day 0, the myocytes is long and rectangular with a clear 
appearance. Myocytes with this appearance adhere to the culture surface, remaining attached between 
media changes an indication of cellular viability. The stem cells are circular and detached when first 
introduced to the culture of myocytes. After a day, stem cells attach to the culture surface and elongate, 
as well as orient themselves in contact with the heart cells, resting in physical contact. After 5 days of 
co-culture, myocytes begin to round out and lose their striated appearance. A few myocytes retain their 
A B C D E 
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striated rectangular appearance, these cells are typically not co-localized with a MSC, which may be the 
reason for this. After the loss of striation, clusters of multiple cells begin to appear on the stem cells, and 
after two weeks in culture, these pairings of cells become large spheroid bodies. The cells within these 
bodies are small and round, containing no patterned structure within them.  
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3.11 Results: Spheroids increase in area over time 
 
The surface area of the cardiac spheroids was calculated by tracing the outline of the spheroids 
in Image J and using the software to calculate area. Surface area was averaged with other spheroids in 
the well. This average was compared over time and as depicted in Figure 10, the average area rose from 
roughly 30,000um2 to about 350,000um2. This difference is statistically significant based on a Student’s 
T-test with a p-value of less than or equal to 0.05. The null hypothesis was that the surface area 
between the two time points was the same. Surface area was chosen to be used as an indicator of size 
as it is a more robust measurement than diameter. Taking the diameter assumes a circular shape, while 
surface area is independent of shape. 
 
Figure 10: The average surface area of the colonies increases significantly between two and four weeks based on a Student’s 
T test with a P-value less than or equal to 0.05. The null hypothesis was that there was no difference in area between the 
two time points. 
* = P ≤ 
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3.12 Results: Cells within cardiac spheroids stain positive for cell cycle 
markers 
  
 To determine if cellular proliferation was occurring within the cardiac spheroid bodies, the 
presence of the protein ki-67 within the cardiac spheroids at two weeks was examined using a 
monoclonal antibody. Some cells within the cardiac spheroids did stain positive for ki-67 as shown in 
image A of Figure 11. Further, the ki-67 signal was co-localized with the blue Hoechst nuclear 
counterstain. This is where the ki-67 would be expected to be found because the protein acts in the 
nucleus. As a second means of examining the co-cultures for proliferation was added to the culture 
media. Edu works by incorporating into the DNA of a cell when the double helix unwinds for replication. 
Image B Figure 11 shows a cell above the feeder layer of stem cells, this cell has incorporated Edu into 
its DNA, suggesting the cell has undergone proliferation. The location of the cell, above the first layer of 
MSCs attached to the culture surface as well as its elongated shape suggest it is a cardiac myocyte. 
These two processes were done with a pure culture of cardiac myocytes after two weeks of culture, and 
no positive signal was found.  
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  Cardiosphere cells are positive for cell cycle markers  
 
Figure 11: Image A shows nuclei within the cardiosphere that have stained positive for the proliferative marker Ki-67. Image 
B shows a single myocyte that has incorporated EDU into its DNA suggesting DNA replication. The location of this cell in 
culture, above the monolayer of MSCs, as well as its appearance suggest it is a myocyte.  
 
 3.13 Results: Myocyte number increases in low density co-culture 
 
One to five myocytes were plated in a 96 well plate such that the total myocyte number could 
be counted and tracked. Half of the wells were co-cultured with MSCs and the other half were used as 
controls for comparison. The results of low density plating yielded between zero and ten myocytes per 
well of the 96 well plate.  After ten days, the number of myocytes in the co-culture group had risen an 
average of about one cell, while cell number dropped in the pure culture by an average of roughly half a 
cell. These results are depicted graphically in Figure 12. This change in cell number is statistically 
significant based on a Student’s T-test with a p-value of less than or equal to 0.05. The null hypothesis 
was that myocyte number was the same after 10 days in culture. Myocytes were identified from the 
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MSCs and counted based on their darker granular appearance. The entirety of the well was scanned 
when counting to ensure no cells were missed.  
 
Figure 12: This graph depicts the change in cell number over 10 weeks for myocytes seeded at very low density in a 96 well 
plate. Myocytes cultured with hMSCs increased in number while myocytes alone decreased. The difference proved to be 
statistically significant based on a Student’s T-test with a p-value less than or equal to 0.05. The null hypothesis was that cell 
number was the same after 10 days of culture.  
3.14 Discussion: Co-culture yields to the formation of cardiac spheroid 
bodies 
 
As hypothesized, when cultured in direct contact with each other, myocytes and stem cells 
spontaneously form spheroid bodies. These bodies are not striated or have striated sarcomeres like 
adult myocytes, nor do they have the clear appearance and elongated shape of a mesenchymal stem 
cell. Instead they are unique entities which does not form in a pure culture of either parent cell type. 
The cells within the bodies do not resemble in appearance a myocyte nor a stem cell. These bodies look 
N=16 
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similar to those found in myocyte/ADSC (adipose derived stem cells) co-culture and CPSs. They are dark 
in color, appear to be granular, and are relatively large compared to an individual cell. Additionally, the 
cells in the spheroids have lost their striation, similar to the cells Rodriguez reported in ADSC/myocyte 
co-culture and what was observed with CPSs. Further investigation is required to establish the 
composition and origin of the spheroids. This information will offer clues into the relationship between 
MSCs and myocytes as well as their potential for clinical use post MI. One major limiting factor of this 
experiment is the variability in the viability of the myocytes derived from cardiac myocyte isolation. This 
makes it difficult to compare the number of spheroids derived between myocytes from different 
isolations.  
3.15 Discussion: Cardiac spheroids stain positive for alpha-actinin 
  
Actinin staining revealed that a substantial proportion of cells within the spheroid bodies are actinin 
positive. This suggests that spheroids are derived mostly of cardiac mycoytes, as mesenchymal stem 
cells have not been shown to be able to differentiate into myocytes when cultured in-vitro and, as such, 
do not produce actinin 48. Because of their cardiac lineage, the spheroid bodies can be called cardiac 
spheroid bodies. This finding shows that the cardiac spheroid bodies share a similar origin with 
spheroids formed from myocyte/ADSC co-culture as they are both derived from mature cardiac 
myocytes. Additionally, the formation of myocyte derived spheroids shows that the mesenchymal stem 
cells interact with the myocytes, causing them to form the cardiac spheroid bodies when in co-culture 
with MSCs, but not when myocytes are alone.  One limitation of this experiment was not being able to 
derive what percentage of cells within the spheroid were actinin positive. This cannot be done for two 
reasons: one, the nucleus of a myocyte does not reside in the cellular body and therefore is difficult to 
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associate with that respective body, secondly, some myocytes are binucleated so there is not a direct 
correlation between nuclei number and the number of cells in a spheroid.  
 
3.16 Discussion: Myocytes in co-culture lose striation 
 
The striation of a fully differentiated myocyte comes from the cable like structure of the 
sarcomere, responsible for cellular contraction. During myocyte proliferation, the sarcomere 
disassembles and subsequently the cell loses its striation. The loss of striation of myocytes within the 
spheroids may be a sign that the cells have entered the mitotic cycle. Striation is also an indication of the 
state of differentiation of the cell. The lack of an organized sarcomere indicates that the cell is no longer 
a fully differentiated cardiac myocyte. Cells within CPSs and myocyte/ADSC co-culture induced spheroids 
also are not fully differentiated myocytes, instead expressing some proteins associated with stem cells 
and some found in mature myocytes 54, 55.  
 
3.17 Discussion: Cardiac spheroids increase in area over time  
 
After the cardiac spheroids form, they significantly increase in surface area over time. Growing 
the cardiac spheroids over time may make them more effective as a therapeutic agent post MI as larger 
spheroid contain more material to replace myocardium lost to an infarct. This growth could be 
attributed to cellular division, hypertrophy, or movement of the MSCs into the cardiac spheroids. The 
growth of the cardiac spheroids is substantial and unlikely caused by hypertrophy, though the size of 
individual cells was not quantitatively measured, a step that would be necessary to prove this. 
Movement of the MSCs into the cardiac spheroids could cause this increase in size. Non-myocyte 
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migration does not compromise the cardiac spheroids as a potential therapeutic agent for treatment of 
MI as cells are either taken from the patient or MSCs that have been shown to be immuneprivileged 24. 
Staining for cell cycle indicators was done to establish if proliferation was a factor in the increase of 
spheroid size. One limitation of this study was the use of surface area instead of total spheroid volume. 
Surface area was calculated from an image looking down on the spheroid and is not as accurate a 
measurement of spheroid size as the volume of the spheroid would be. Ideally, we would be able to 
compare the mass of the spheroid from 2 weeks to 4 weeks.  
 
3.18 Discussion: Cells within cardiac spheroids stain positive for cell 
cycle markers 
 
At two weeks, cells in the spheroids stained positive for the cell cycle marker ki-67, additionally 
myocytes incorporated EDU into their DNA when exposed to the substance, also an indication of DNA 
replication. These findings suggest that cells within the spheroid and cardiac myoctes are proliferating, a 
phenomenon witnessed in the border region of infarcts 40. These results suggest that myocyte 
proliferation plays a role in the observed increase in size of the cardiac spheroids. This is relevant as an 
increase in total myocyte cell number may make the cardiac spheroids more effective as a therapeutic 
agent for MI. Further, it can be inferred that this is a result of co-culture with hMSCs as myocytes alone 
do not stain positive for Ki-67. One point of consideration when examining these results is the difficulty 
in associating a Ki-67 positive nucleus with an actinin positive cell. The nuclei of a myocyte does not 
reside centrally within the cellular body giving rise to the difficulty of associating the nuclei with the cell 
body.  
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3.19 Discussion: Myocyte number increases in low density co-culture 
 
To determine if the positive staining for the cell cycle marker Ki-67 corresponds to daughter cell 
formation, myocyte number was tracked in low density co-culture. It was found that the total number of 
myocytes did significantly increase over ten days as compared to a control of myocytes cultured alone, 
also plated at low density. This suggests that DNA replication in the cardiospheres is a precursor to 
cytokinesis and subsequently daughter cell formation. This is significant as it suggests that a population 
of cardiac myocytes can be increased in number through hMSC co-culture. As such, a small biopsy of 
autologous myocytes could be taken from a patient, and by co-culture with allogenic or autologous 
MSCs, expanded to a larger quantity of cells and then delivered to an MI. This would provide tissue to 
restore contractile force, while limiting the damage done to the heart from the initial biopsy. This is a 
limitation of cardiac stem cells used to create cardiospheres, they require a large amount of initial 
cardiac tissue. It is necessary to limit the size of any biopsy taken from the heart in order to reduce the 
reduction in cardiac capacity that this could cause. A limitation of this study was the inability to plate a 
consistent number of myocytes in each well to being the experiment. This would have facilitated direct 
comparison between the number of myocytes at the end of the experiment between wells.  
3.20 Aim1 Discussion  
 
The data from aim one supports the hypothesis that myocyte/MSC co-culture yields to the 
creation of cardiac spheroid bodies. It is the similarity to the spheroids derived from cardiac progenitor 
cells, as well as those made from myocyte/ADSC co-culture is one reason to believe that these cardiac 
spheroid bodies could be effective as therapeutic agents for cardiac infarction. Both the cardiac 
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spheroids derived from myocyte/MSC co-culture and those previously documented are comprised of 
cardiac cells, stain positive for ki-67, and have a similar shape and appearance 48.  
One important thing to note from aim 1 is the difference in species between the two cells in co-
culture. The myocytes are derived from a rat while the MSCs are human. As the intended aim of creating 
these cardiac spheroids is to use human cells, it must be confirmed that these results translate when 
human myocytes are used. Rat and human cardiac myocytes contain many of the same proteins and 
organelles. This suggests that human myocytes may behave in the same fashion as rat myocytes when in 
co-culture. Human cardiac spheroids have been generated with cardiac progenitor cells which illustrates 
human myocytes are able to form spheres 44. 
A limitation of this study is the inability to identify the location of the MSCs in the co-culture. 
This ability would allow us to determine if MSCs were present in the spheroids and contributing to the 
increase in surface area. Another limitation is not being able to count each individual cell within the 
spheroid. Using Hoechst staining to count the nuclei would not be accurate as some cardiac myocytes 
have two nuclei while others do not. Knowing how many cells were in the spheroid would be useful to 
determine the final number of spheroid derived cells that were generated. The inability to remove the 
non-myocyte cardiac cells during the myocyte isolation process is also another experimental limitation. 
These cells could be secreting proteins that affect spheroid formation or the cells could be incorporating 
into the spheroid itself. This is a variable that must be accounted for to determine if it is the co-culture 
of myocytes and MSCs that is responsible for spheroid formation.  
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Chapter 4, Aim 2: Determine role of non-myocyte cardiac cells in 
spheroid formation 
  
4.1 Methods: Isolation of non-cardiac myocyte cells  
 
In order to separate the non-myocyte cells from the myocytes, 3mls of supernatant were 
removed during the myocyte counting process, following the isolation of the cardiac myocytes as 
described in aim 1. This solution contained the cells from the heart that were lighter than the myocytes. 
As myocytes are relatively heavy cells this suspension of lighter cells was composed of predominantly 
non-myocyte cardiac cells. These are the cells that are difficult to eliminate from the myocyte/MSC co-
culture.    
 4.2 Methods: Pure cultures of myocytes and MSCs 
 
In order to establish if the cardiac myocytes or MSCs are able to spontaneously form spheroids 
in the absence of the other cell type, pure populations of each cell were cultured. MSCs were thawed as 
explained in aim 1 and plated in a 24 well plate, at a density of 5,000 MSCs per well. MSCs were cultured 
in DMEM with 10% Fetal Bovine Serum and 1% Penicillin/streptomycin, media was changed every other 
day. Myocytes were isolated in the manner as described in aim 1 and plated in a 24 well plate, 5,000 
myocytes/well. Myocytes were cultured with the same media and in the same fashion as the MSCs. 
Following two weeks of culture, the wells were examined for cardiac spheroid formation.  
48 
 
  
 
4.3 Methods: Co-culture of non-myocyte cells with MSCs 
 
After determining cellular density, the cell solution was diluted such that 5,000 non-myocyte 
cells were plated in each well of a 24 well plate. This equates to 5,000 cells per ½ of a milliliter of media. 
Co-culturing was done in the same manner as aim 1 with the exception that the original media of the 
non-myocyte cells was not changed until the MSCs had been added to the culture for 24 hours. This was 
to prevent unattached cells from being washed away without giving them a chance to interact with the 
MSCs. After this point, the co-cultures were treated and analyzed in the same manner as aim 1, cardiac 
spheroids were counted and a Student’s T-test was used for comparison.   
 4.4 Methods: Co-culture of non-myocyte cells with myocytes 
 
To culture the myocytes and non-myocyte cells together, the two populations of cells were 
isolated as previously described and then plated simultaneously. The cells then sat for 24 hours prior to 
changing the media, this was done to allow for the detached non-myocyte cells to possibly make 
interactions with the myocytes. The media was then changed and cultures were run for two weeks at 
37oC. DMEM with 10% FBS and 1%P/S was used to culture the cells with, media was changed every two 
days. After two weeks of culture, wells were examined for spheroid formation.  
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4.5 Results: Pure cultures of MSCs or Myocytes do not yield cardiac 
spheroid formation  
 Cardiac myocytes and MSCs were grown separately to establish if one or both cell types, alone, 
would be able to form cardiac spheroid bodies. After two weeks in culture, spheroid bodies could not be 
found in either of the pure cell populations. Figure 13 shows a picture of cells after two weeks of 
culture.  In both circumstances the cells have remained separate and do not shown any grouping as was 
seen in the myocyte/MSC co-cultures. Further, most cells retain their initial appearance and shape, 
unlike in co-culture, where the myocytes lose their striation and rectangular shape. These findings were 
consistent in every well tested. Myocytes or MSCs when cultured alone do not yield to the formation of 
cardiac spheroid bodies.   
Figure 13: Pure cultures of myocytes (A) or MSCs (B) do not yield to the formation of cardiac spheroids 
A B 
Pure culture of MSCs Pure culture of myocytes 
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4.6 Results: Co-culture of non-myocyte cells with MSC does not yield 
cardiac spheroid formation  
 
When the non-myocyte cells, extracted from the cardiac myocyte isolation process, were co-cultured 
with MSCs, cardiac spheroid bodies did not form. Figure 
14, shows an image of a MSC/non-myocyte co-culture after 
two weeks. The culture of cells is absent of any bodies 
resembling the cardiac spheroids found in myocye/MSC 
co-cultures. The non-myocyte cardiac cells cannot be 
found in the culture after two weeks, suggesting they did 
not attach to the layer of MSCs coating the culture surface. 
This was confirmed with an inverted microscope used on 
live cell cultures. This suggests that any non-myocyte 
cardiac cells remaining after the isolation process wash 
away during culture and do not play a role in manipulation of the cardiac myocytes. Further, these 
results show that the non-myocyte cardiac cells do not directly contribute to the formation of the 
spheroid bodies.  
Figure 14: Image of MSCs cultured with non-myocyte 
cardiac cells after two weeks. Spheroids did not 
form. 
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4.7 Results: Co-culture of myocytes with non-myocyte cells does not 
yield spheroids 
 
After establishing that MSCs and non-myocyte cardiac cells are unable to form spheroid bodies 
together, it was necessary to test if the direct contact 
between myocytes and non-myocyte cells could yield 
spheroid bodies. Myocytes were cultured with the non-
myocyte cells taken during a myocyte isolation. Significant 
colony formation was not seen. Figure 15, to the left, shows 
an image of the myocyte/non-myocyte co-culture after two 
weeks. The yellow arrows point out the individual myocytes. 
Note that the culture is void of any spheroid like bodies. The 
myocytes also have not become globular or granular as observed in the myocyte/MSC co-culture.  
4.8 Discussion: Pure cultures of MSCs or myocytes do not yield cardiac 
spheroid formation  
 
The finding that, alone, MSCs or cardiac myocytes cannot form spheroid bodies demonstrates 
that the interaction between the two cell types is what leads to spheroid genesis. Though the spheroids 
are heavily actinin positive, suggesting a large presence of myocytes, the MSCs are vital for spheroid 
Figure 15: Image of co-culture of myocytes with 
non-myocyte cells after two weeks in culture. 
Culture is void of spheroid bodies. Yellow arrows 
point out the individual myocytes 
52 
 
formation to occur. This suggests that the MSCs are manipulating the other cells in culture, altering their 
behavior and causing spontaneous spheroid creation. As it is extremely difficult to obtain a 100% pure 
population of cardiac myocytes, it is necessary to establish what cells the MSCs are manipulating, the 
cardiac myocytes or the other cell types derived and plated during myocyte isolation.  
 
4.9 Discussion: Co-culture of non-myocyte cells with MSC does not yield 
spheroids 
 
Cardiac progenitor cells are one of the non-myocyte cells that could be present in the 
myocyte/MSC co-culture. As these cells have been shown to be capable of forming spheroid bodies, it is 
important to establish if they are the cause of spheroid genesis in myocyte/MSC co-culture. Further, any 
other cell type, besides myocytes and MSCs, must be eliminated as a reason for spheroid genesis. The 
lack of spheroids in the non-myocyte cardiac cell/MSC co-culture illustrates that cardiac myocytes are 
the cell type that drives myocyte/MSC co-culture spheroid creation. Non-myocyte cardiac cells from the 
isolation process, such as progenitor cells, do not form the spheroids. This is significant as cardiac 
myocytes are far more abundant than cardiac progenitor cells, which makes them a better option for 
producing cardiac spheroid bodies for post MI cardiac repair.  
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 4.10 Discussion: Co-culture of myocytes with non-myocyte cells does not 
yield spheroids 
 
By finding that spheroids will not form when mycoytes and non-myocyte cardiac cells are co-
cultured in the absence of MSCs, it can be concluded that the non-myocyte cells are not responsible for 
the change in appearance and behavior of the myocytes when in myocyte/MSC co-culture.  This 
eliminates other cells besides the MSCs as the reason why the myocytes change morphology and form 
cardiac spheroid bodies.  
 
 4.11 Discussion  
 
As the spheroids are predominantly comprised of myocytes, and also necessary for spheroid 
formation, this suggests that the stem cells are influencing the myocytes to congregate and form 
spheroid bodies. Based on the positive proliferative staining found within the spheroids, the hMSCs may 
also be responsible for the myocytes reentering the cell cycle. These findings support current research 
about the relationship between MSCs and myocytes 48. Specifically, that MSCs are able to reprogram 
myocytes and induce proliferation. What is novel is the finding that the myocytes, in long term co-
culture with MSCs, form cardiac spheroids similar to cardiac progenitor derived spheroids 48.  
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It was also found that non-myocyte cardiac cells cannot form spheroids, nor can they cause 
spheroids to form when co-cultured with MSCs or myocytes. This eliminates them as a cause for 
spheroid genesis. The co-culture of MSCs with myocytes is the driving force behind spheroid formation.  
A limitation of this experiment was not knowing the specific cell types that comprised the non-
myocyte cardiac cells. They could have been fibroblast, resident stem cells or another cell type. Knowing 
their specific identity would have helped us understand how they could have been interacting with the 
mycoytes or MSCs in co-culture.  
The change of the culture surface from CC2 coated 4 well chamber slides to tissue culture plastic 
24 well plates is another variable that should be noted. This culture surface may alter the formation of 
the cardiac spheroids.  
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Chapter 5, Aim 3: Determine role of MSCs in spheroid formation  
 
In Aim 1 It was established that the co-culture of cardiac myocytes and hMSCs results in the 
formation of cardiac spheroid bodies, but the specific role that the MSCs play in this process is not 
known. The goal of aim 2 was to determine the capacity in which MSCs contribute to cardiac spheroid 
formation. Two variables were investigated, the necessity co-culture and the correlation between 
myocyte to MSC ratio and cardiac spheroid formation. Establishing if MSCs must be in direct contact 
with the MSCs is important when considering the mechanism of cardiac spheroid formation, as well as 
how the spheroids might be used as therapeutic agents. Knowing how myocyte MSC ratio affects cardiac 
spheroid formation is relevant in establishing how many MSCs are necessary to make the cardiac 
spheroid bodies.  
5.1 Method: MSCs conditioned media on cardiac myocytes 
 
The objective of this experiment was to expose a pure culture of myocytes to the cytokines that 
MSCs release to determine if cardiac spheroids could be made without direct MSC/myocyte contact. 
Three groups were used in this experiment, myocytes cultured alone as a control, myocytes cultured in 
MSC treated media, myocytes cultured in 50% MSC treated media and 50% fresh media, and myocytes 
cultured with MSCs in direct contact. The 50% fresh 50% conditioned experimental group was used to 
replenish the media with nutrients lost during MSC culture. The control co-culture was done to establish 
if the isolated myocytes were viable enough to generate spheroids. Cardiac ventricular myoctes were 
isolated and plated in the same fashion as described in aim 1. MSCs were prepared and co-cultured in a 
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24 well plate with the myocytes, 5,000 of each cell type were seeded per well. 1milliliter of DMEM with 
10% FBS 1%P/S was placed in the wells with the MSCs for 24 hours. Media was removed and placed 
directly on the plated myocytes for the MSC treated media group and diluted with an equal volume of 
fresh DMEM for the 50/50 group. Myocytes were incubated with the treated media for 2 days before 
fresh media was added. For the purpose of counting, cardiac spheroids were defined as 5 or more cells 
in intimate contact. Each well was counted by three people and the counts were averaged. Counts were 
taken one day after myocyte plating, prior to MSC co-culture, 4 days after co-culture, 7 days after co-
culture, and 14 days after co-culture. Counts were then compared from day 0 to day 14 using a Students 
T-test with a null hypothesis that spheroid counts were the same. To compare the day 14 spheroid 
counts between groups a one way ANOVA was ran using a null hypothesis of all groups being the same.    
5.2 Method: Co-culture with varying myocyte:MSC ratios  
 
The purpose of this experiment was to establish if there is a correlation between the number of 
stem cells per myocyte and total spheroid formation. Six groups were compared: myocytes alone as a 
control, a 1:2 MSC to myocyte culture ratio, a 1:1 MSC to myocyte culture ratio, a 2:1 MSC to myocyte 
culture ratio, a 5:1 MSC to myocyte culture ratio, and a 10:1 MSC to myocyte culture ratio. The number 
of cells used was calculated with a baseline of 5,000 myocytes per well and a varying the number of 
MSCs to achieve the desired myocyte to MSC ratio for each experiment. Respectively the number of 
MSCs used in each group were: 0, 2,500, 5,000, 10,000, 25,000, and 50,000.  The cultures were grown in 
DMEM with 10% FBS 1%P/S at 37oC. Media was changed every other day. After two weeks in culture, 
spheroids were counted and compared between groups. A one way Anova was run to determine if 
significant difference existed between the experimental groups. The null hypothesis was that there was 
no difference and a p-value of 0.05 was used. A paired Student’s T-test was also done to compare the 
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day 0 spheroid counts to the day 14 spheroid counts. The null hypothesis was that there was no 
difference in the number of spheroids counted at each time point and a p-value of 0.05 was used.  
5.3 Results: Media exchange does not increase spheroid formation 
 
To establish if the intimate contact between myocytes and stem cells is necessary for the 
creation of cardiac spheroids, myocytes were treated with stem cell conditioned media. To create the 
stem cell conditioned media, DMEM was cultured with hMSCs for 24 hours, such that the proteins 
secreted by the hMSCs would be captured and later introduced to the myocytes. To account for nutrient 
depletion, a 50/50 mix of fresh and conditioned media was used for a second experimental group. As 
shown in Figure 16 , the media exchange groups did not generate a statistically different number of 
cardiac spheroids from 
myocytes cultured with 
normal media. However, 
the co-culture group 
generated a statistically 
significant different 
number of cardiac 
spheroids from the 
control.  
Figure 16: Cardiac spheroid formation in myocytes treated with stem cell conditioned media as compared to a direct contact 
myocyte/hMSC co-culture. A statistically larger number of spheroids are derived from co-culture as compared to the other 
groups. A one way ANOVA was done using a p-value of less than or equal to 0.05 (*). The null hypothesis was that colony 
number was the same between time points. Error bars are one standard deviation.  
 A point of interest is the upward trend of colony count over the time course of the experiment; 
this was not observed in the control group. This could suggest that spheroids are forming in the media 
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exchange groups, but not in a large enough quantity to be statistically significant, like the co-culture 
group.  
 
5.4 Results: Cardiac Spheroids reside on top of a layer of hMSCs 
 
Three dimensional confocal microscopy was used to create a three dimensional movie of a 
spheroid, reconstructed from a z-stack of successive images. Figure 17 shows the mass of cells from the 
side, from which it can be seen that the spheroid grows vertically from the culture surface. The Hoechst  
stain, blue, visualizes cell nuclei and the actinin stain, 
green, is specific to myocytes. Hoechst signal not 
associated with actinin signal denotes location of the 
MSCs. Almost all of the nuclei associated with actinin 
signal are located above the nuclei void of actinin 
signal. The myocytes have assembled above the MSCs 
located on the culture surface.  
 
  
  
 
 
5.5 Results: MSC to myocyte ratio does not increase cardiosphere 
formation 
 
Figure 17: A 3 dimensional image of a myocyte/MSC co-
culture. The myocytes are stained for actinin (green)  
while the MSCs are identified by blue nuclear signal 
without green signal near. The image illustrates how the 
myocytes reside on top of the MSCS, depicted in cartoon 
below the image.  
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After establishing the need for direct co-culture, the importance of the total number of MSCs 
was examined. Using the same number of myocytes, a variable number of stem cells was used in co-
culture. Figure 18 shows the results of this experiment, the varying ratios used are depicted on the 
horizontal axis. 
 
Figure 18: Myocyte/hMSc co-cultures using variable ratios of stem cells to myocytes. The formation of cardiospheres is 
independent of cell ratio. Total spheroid number increased significantly in all the groups except the 0:1 ratio. A one way 
ANOVA was done using a p-value of less than or equal to 0.05 (*). The null hypothesis was that spheroid number was the 
same between time points of a ratio. A second ANOVA was done with the same criteria, but using a null hypothesis that day 
14 spheroid number was the same between ratios. Error bars are one standard deviation. 
These data demonstrate that within each co-culture group there was a statistically significant 
rise in the number of cardiac spheroid bodies, with the exception of the 5:1 ratio group. Though there 
appears to be an increase in spheroid number from day 1 to day 14 in the 5:1 group, it is not statistically 
significant. In general, regardless of the ratio of hMSCs to myocytes, co-culture yields to the formation 
of cardiac spheroids in roughly the same number.  
N=6 
* = P ≤0.5 
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5.6 Discussion: Spheroids reside on top of a layer of hMSCs 
 
Actinin staining of the myocyte/MSC co-cultures imaged with the confocal microscope revealed 
that the cardiac spheroids rested on top of the MSCs. These findings illustrate that the population of 
myocytes predominantly do not remain on the culture surface. This further supports the finding that the 
spheroid bodies are comprised of predominately cardiac cells. The interesting observation about the 
orientation of the cells is that not all of the myocytes are in direct contact with MSCs. Once the cardiac 
spheroids form, cells expand out away from the MSCs adhered to the culture surface, yet retain their 
non-striated spherical appearance. This could prove to be helpful when attempting to remove the 
spheroids from the culture surface. 
5.7 Discussion: Media exchange does not increase spheroid formation 
  
The most substantial finding from this experiment was that MSC conditioned media was unable 
to generate a statistically significant number of cardiac spheroids in a culture of pure myocytes. The 
inability of the media exchange groups to form a statistically different number of spheroids at the end of 
the experiment could be a failure to reject the null hypothesis based on too small of a sample size. Stem 
cell treated media may be giving rise to spheroids, just not as effectively as myocyte co-culture. Only 
direct myocyte/MSC co-culture led to a significant increase in cardiac spheroid number. Rodriguez et al. 
reported finding direct contact between MSCs and myocytes, these structure may be the key to the 
formation of spheroid bodies as they can only form when MSCs and myocytes are in direct contact. 
These findings suggest it is the direct co-culture that drives the change in appearance and behavior of 
the myocytes.  
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 Another point of interest with this experiment was the upward trend over time of spheroid 
bodies in both conditioned media groups. Though not statistically significant, the number of counted 
spheroid bodies rose over time. This could be because some of the proteins secreted by MSCs have 
been shown to induce cellular proliferation 39}. It is possible that the process of changing the media 
damages these proteins in some way and therefore lessens their function.  
 The culture conditions in which the medium was exposed to the MSCs does not directly reflect 
the conditions the MSCs are in when being co-cultured. Specifically, they are not exposed to myocytes. 
This may change the nature of what is being secreted from the MSCs. Therefore, the composition of 
MSC secretions in the conditioned media may not be exactly what is in the co-culture media. The half-
life of these secretions is also a limited factor. If they secretions are breaking down before being placed 
on the myocytes, they myocytes may not be experiencing the same secreted factors as they would in co-
culture.  
 
5.8 Discussion: MSC to myocyte ratio does not increase spheroid 
formation  
  
The number of MSCs in culture per myocyte does not directly correlate to more spheroid 
bodies, further suggesting that the MSCs act as a triggering agent to myocyte reprogramming. If the 
myocytes required the MSCs for the duration of spheroid formation and growth, it would be expected 
that more MSCs would mean more spheroids. However, if they are only needed to trigger the 
reprogramming of myocytes, than a few MSCs could have the same impact on a population of myocytes 
as a larger group of MSCs, which was what was witnessed in this experiment.  
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Figure 19: Variable ratio experiment conducted with 3 
spheroid counters. Graph appears similar to that 
depicting data from one counter. 
This fact also suggests that MSCs do not directly make up the spheroid bodies. If MSCs were 
migrating into the spheroid bodies or were initially being incorporated into them, it would be expected 
that more MSCs would correlate to more spheroid bodies.  
To determine if a counting bias contributed to the results, specifically with the 5:1 group, two 
additional counters were used to verify the data. A counting bias could occur from the counter changing 
the definition of a spheroid based on what group he/she is counting. Figure 19  shows that this trend 
was observed when the counting process was replicated.  
One limitation of this study was the surface area of the spheroids generated were not examined. 
There may be a correlation between the ratio of MSCs to myocytes and the size of the spheroids that 
could impact spheroid number.  
  
5.9 Aim 3 Discussion  
 
 In Aim 2 it was shown that direct myocyte 
to MSC contact is helpful for cardiac spheroid 
bodies to form. This is significant when considering 
using MSC derived spheroid bodies for clinical use, 
as well as the relationship between MSCs and 
myocytes. The original hypothesis that direct contact 
is needed is supported.  
 The second hypothesis of aim 3, the number of MSCs in culture will be directly proportional to 
the number of spheroid bodies that form was not confirmed. No strong trend between myocyte/MSC 
ratio and spheroid number was found.  
* = P ≤0.5 
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 These two findings suggest that the MSCs trigger a change in appearance of the mature 
myocytes that results in spheroid formation. Further, it is not likely that MSCs directly contribute to the 
population of cells comprising the spheroid bodies or it would be expected that more MSCs would yield 
more spheroid bodies. These conclusions suggest that a relatively small population of MSCs would be 
able to produce a large number of spheroid bodies.   
Chapter 6: Discussion 
 
In order to mitigate the effects of myocardial infarction, it is necessary to replace the dead 
tissue with new mechanically active myocytes. Current technology fails to adequately accomplish this. 
This investigation has shown that isolated cardiac myocytes can be made, through stem cell co-culture, 
to form cardiac spheroid bodies. These spheroid bodies grow over time and increase in number. For this 
process to happen the myocytes and stem cells must be in direct co-culture. The relevance of these 
findings in the context of post infarct cardiac regeneration will be discussed in this section.  
6.1 Formation of spheroids 
  
The main objective of this study was to derive a potential cell source for regenerating 
myocardium after an infarction. The combination of myocytes and MSCs was chosen for several reasons. 
One, MSCs appear to not illicit a rejection response from the immune system when used in the context 
of cardiac regeneration16.  For clinical applications, an autologous source of myocytes would have to be 
used and therefore would also not be rejected by the immune system. The biggest advantage cardiac 
myocytes hold in terms of cardiac regeneration is that they contain the proteins necessary for 
contraction, as well as electrical coupling with native myocardium 32. Other cell types used to treat MI, 
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such as stem cells or skeletal muscle, must be cohersed to make these proteins if they are to form 
beating units in the heart.  
hMSCs were chosen as a conditioning agent to the ventricular myocytes based on their ability to 
reprogram cardiac myocytes14. Additionally, when hMSCs and myocytes are implanted together into an 
infarcted rat heart, they are able to restore more functionality than myocytes or stem cells implanted 
alone17. This suggests that these two cell types are able to work in conjunction to regenerate 
myocardium. It is known that adult myocytes and stem cells are able to form inter-cell gap junctions, as 
well as nanotubes, through which cytoplasm is exchanged14.  Further, hMSCs have been shown to be 
able to promote proliferation of cardiac myocytes, as well ‘protective reprogramming of injured adult 
myocytes’ 54. It is for this reason that hMSCs were chosen to condition the isolated myocytes, such that 
they may promote proliferation and potentially cause the formation of cardiac spheroid bodies, similar 
to those made from cardiac progenitor cells. Cardiac progenitor-derived spheroids are significant as they 
have been shown to be the most promising cell type for post MI-therapy, though the rarity of cardiac 
progenitor cells in the heart limits the ability to make a large number of spheroids in a safe and timely 
manner [Marban, 2010]. If a similar cell type could be generated from mature myocytes, which are 
much more abundant in the heart, this limitation could be overcome.  
When myocytes and stem cells were cultured together, cardiac spheroid bodies did form. These 
spheroid bodies resembled the cardiospheres formed from the isolation and expansion of cardiac 
progenitor cells. The cardiac stem cell derived spheroids showed greater potential to mitigate the 
effects of a MI as compared to all other cell types used for that application 42. As these bodies are similar 
in composition to the myocyte/stem cell co-culture derived spheroids, it suggests that cardiac spheroid 
bodies hold promise as an effective agent to aid the heart in healing post MI. The similarities between 
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cardiac progenitor cell derived spheroids and myocyte/MSC co-culture derived spheroids is the reason 
for this belief.   
Table 2 lists the common traits between cardiac progenitor cell derived spheroids and those made from 
myocyte/MSC co-culture.  
Table 2: Shared traits between CPS and myocyte/MSC derived spheroids 
Similarities between CPS and myocyte/MSC derived 
spheroids 
Round spheroid bodies comprised of granular cells 
Autologous cardiac lineage 
Spheroid number increases over time 
Ki-67 positive  
 
The cells found in the myocyte/MSC-derived spheroids have the potential to restore heart function and 
can be made with less cardiac tissue than cardiac progenitor derived spheroids.  Figure 20 below 
illustrates the contrast in the availability of the cells used from the cardiac biopsy to make progenitor 
cell derived spheroids as compared to myocyte/MSC co-culture derived spheroids. They key difference is 
the abundance of myocytes in the heart as compared to the small amount of cardiac progenitor cells. 
For every 10,000 myocytes in the heart there is only one cardiac progenitor cell. In the context of 
making spheroids, this means there are more cells capable of making spheroids using myocyte/MSC co-
culture in a biopsy than cells capable of making CPSs.   
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Figure 20: Comparison between the cells used from cardiac biopsies in order to make progenitor cell derived spheroids vs. 
myocyte/MSC co-culture derived spheroids. 
Another point of comparison between our spheroids and those made from cardiac progenitor cells are 
their size. After 25 days of culture, progenitor derived spheroids are about 200 microns in diameter 
[Marban, 2006]. Though the myocyte derived spheroids are smaller after 2 weeks, roughly 50 to 100 
microns in diameter, after 4 weeks in culture they are roughly the same size as the progenitor cell 
derived spheroids. 
One thing that remains unclear about the formation of the cardiac spheroids is the mechanism by which 
the MSCs act on the cardiac myocytes. In aim 2, it was found that direct myocyte/MSC co-culture is 
advantageous for spheroid genesis, offering some insight into how the MSCs communicate with the 
myocytes. These results suggest that direct co-culture of the two cell types is beneficial for spheroid 
formation, and therefore, paracrine factors secreted by the MSCs may not substantially contribute to 
the creation of spheroids. It is possible that the separation of the myocytes and MSCs may change the 
factors that are secreted by the MSCs. Additionally, the half-life of the secreted cells may play a role in 
the ability of MSC conditioned media to form spheroids when cultured with mycoytes. If the paracrine 
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factors are breaking down prior to being exposed to the myocytes, their effect on the myocytes will be 
diminished. This is another possible explanation as to why direct co-culture yields more spheroid bodies 
than conditioned media. Literature shows that MSCs and myocytes can form nano-tubes through which 
cytoplasm is exchanged 54. This is another possible means by which the MSCs could be influencing the 
myocytes. The implications of this are that it may be difficult to separate the MSCs from the spheroid 
bodies for clinical use. Fortunately, this may actually be advantageous as allogenic MSCs, in the context 
of cardiac regeneration, are immune-privileged and further, have been shown to help mitigate the 
negative effects of an MI 39.  
Determining the role of MSCs in the formation of cardiac spheroids is also important when 
assessing the production of the spheroid bodies. When considering large-scale production of these 
cardiac spheroids, it is necessary to know how many stem cells are needed to create the spheroid 
bodies. The production process must be optimized to limit cost while maintaining yield. It was found 
that stem cell to myocyte ratio did not significantly impact the number of colonies formed. The lower 
boundary for this experiment was one stem cell for every two spheroid bodies. Therefore, future 
experiments should investigate whether colony formation happens below this ratio; in this way the 
number of stem cells needed to produce spheroids could be minimalized.  
6.2 Experimental limitations  
  
One issue that arises when attempting to quantify the number of cardiac spheroids that have 
formed is determining what is and is not a cardiac spheroid.  This can be difficult when multiple 
myocytes are in close proximity. A standard definition of a cardiac spheroid was adopted such that 
consistency was maintained from well to well. Also three counters counted each well that was analyzed 
in order to eliminate possible bias or human error.   
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 A concern when considering the use of these cardiac spheroids for clinical purposes is if the 
hMSCs make up some of the cardiac spheroid. If they do, the implications of implanting them into a 
human heart must be determined. As the mesenchymal stem cells will not instigate a response from the 
host immune system, therefore they are acceptable for therapeutic use if they are forming part of the 
cardiac spheroids.  
 A second concern that arises when assessing the feasibility of using cardiac spheroids for clinical 
use is cell viability within the spheroid. Cells at the center of the spheroid may not be receiving ample 
nutrients due to the limitation of diffusion through the spheroid body. Diffusion becomes inadequate to 
maintain cell function around 200um. To avoid this problem the cardiac spheroids could be harvested 
once their radius reaches 200um. To truly determine if cells within the wells are still viable, the cardiac 
spheroids would need to be fixed and sectioned, such that the inner cells could be stained. This process 
is time intensive and technically challenging and, therefore, was not conducted in this study.  
 6.3 MSCs in the infarcted heart  
  
MSCs have been shown to mitigate the negative impact of myocardial infarction when delivered 
to the heart, yet the mechanism governing this is unknown. The results of this research offer some clues 
as to what could potentially be taking place in the heart between the delivered MSCs and native cardiac 
myocytes. Delivered MSCs could potentially co-localize with the myocytes, as seen in in-vitro co-culture, 
and reprogram the myocytes in the same manner. This could lead to myocyte proliferation effectively 
replacing some of the lost cardiac tissue. This phenomenon, as well as the benefit of cytokines secreted 
by MSCs, could be the way in which MSCs help mitigate the negative impact of MI.
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Chapter 7: Conclusion 
 
This study has shown that by co-culturing ventricular myocytes with hMSCs, cardiac spheroids 
can be created. A similar cell type derived from cardiac stem cells has demonstrated to be more 
effective at restoring contractile force than any other cell type used for cardiac regeneration. The 
myocyte/MSC derived spheroids are similar to the cardiac stem cell spheroids. The advantage they offer 
over cardiac stem cell made spheroids is they require substantially less autologous tissue to create, 
making them safer for the patient and faster to create in large number. The myocyte/MSC co-culture 
derived spheroids contain some proteins found in stem cells and some found in mature myocytes.  
In aim 2 it was found that myocytes cultured with non-myocyte cardiac cells will not form 
spheroid bodies. It was also found that MSCs cultured with non-myocyte cardiac cells will not form 
spheroid bodies. The co-culture of myocytes and MSCs is necessary for spheroids creation.  
The results of Aim 3 illustrated that direct co-culture is required for the number of spheroids to 
statistically increase. There was not a strong correlation between an increase in spheroid number and an 
increase in the ratio of MSCs to myocytes.  
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Chapter 8: Future Work 
 
The first step to furthering the development of myocyte/MSC co-culture derived spheroids is to 
better understand what is occurring within the spheroids in terms of proliferation and cell number. The 
total number of cells that have undergone proliferation could be tracked by adding EDU to the culture 
media and tagging that EDU with a fluorescent antibody. Cells that stained positive for EDU would have 
replicated their DNA while in culture. It would also be useful to count the number of cells within the 
spheroids. Myocytes can contain either one or two nuclei, so therefore, the number of nuclei in a 
spheroid will not necessarily correlate to the number of cells in that spheroid. One possible way to count 
the cells of spheroid is to attempt to dissociate the individual cells from the spheroid with trypsin or 
another protease, then use a hemocytometer to count the cells.  
 Another important step in investigating the potential of the spheroids to restore mechanical 
function to a region of infarct is to investigate the ability of the spheroid cells to differentiate into 
myocytes. This could be attempted by electrical or mechanical pacing of the cells. This would entail 
imparting either a cyclical mechanical strain on the cells or a pulsatile electrical stimulation. The goal is 
to emulate the conditions inside of a beating heart to change the phenotype of the cell. 
Future studies should aim to determine the best delivery vehicle for the cardiac spheroid bodies 
to a rat infarct model. Several delivery techniques should be tested for cellular engraftment to 
determine the most effective method. Once a way to deliver the spheroids is found, they should be used 
to treat a rat model of myocardial infarction. LVEF of the infarcted heart could be used as a metric to 
compare hearts without treatment and a cardio-sphere treated MI. This would gauge the ability of the 
spheroids to restore the ability to pump blood to the damaged myocardium. Once this has been done, a 
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similar experiment should be scaled up to a large animal model. If the myocyte/MSC derived spheroids 
are proved to be safe and effective, human cardiospheres should be made and tested in a human clinical 
trial. Success in clinical trials shifts the focus of study to up-scaling and optimizing the spheroid 
production process.  
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Appendix A: Making Krebs solution (KB) 
 Table of chemicals used and their required quantity per one liter KB.  
Chemical  Grams/Liter 
KCL  1.863 
KH2CL2 1.361 
Glucose 0.285 
75 
 
EGTA 0.190 
Taurine 2.5 
L-glutamic acid 10.29 
HEPES 2.38 
ATP 0.276 
 
• 1 liter of deionized water was measured with a graduated cylinder and place in a 2l beaker 
• Beaker was put on a heating plate set to 30oC with a magnetic stirrer spinning on the bottom 
• All of the ingredients, except for the ATP, were measured out and placed in the 1L of DI water 
• Solution was left to warm and stir until clear, (roughly 30min to an hour) 
• Beaker was taken into a biosafety cabinet and filtered through a 1L Corning Filter system.  
• Filtered contents were stored in at 3-5oC 
• Prior to using KB the appropriate quantity of ATP was measured out and put into solution with 
5mls of DI water.  
• This solution was filtered with a 5ml syringe and a Pall Acrodisk Syringe Filter (0.2um) into the 
KB solution  
 
 
 
